Zacks Investment Research
08 Jun 2026, 17:46 UTC · 1h ago
3 Reasons Why Growth Investors Shouldn't Overlook Dillard's (DDS)
Zacks Investment Research
08 Jun 2026, 17:46 UTC · 1h ago
Story key points
3 claims · impact-rated
Zacks Equity Research recommends Dillard's (DDS) as a top growth stock due to a favorable Growth Score and a top Zacks Rank. — A 'Strong Buy' or 'Buy' recommendation from a major research firm can drive short-term positive sentiment and buying pressure for the specific ticker.
+0.30Dillard's projected EPS growth for the current year is 6.3%, significantly outperforming the industry average of -0.6%. — Positive earnings divergence relative to peers suggests a competitive advantage and fundamental strength.
+0.20Dillard's current sales-to-total-assets (S/TA) ratio is 1.7, indicating efficient asset utilization to generate sales. — Efficiency metrics are secondary indicators of management quality and operational health.
+0.10Ticker attribution
Model heads
Continue reading
6 related stories
The company is explicitly recommended as a great growth pick with a top Zacks Rank and projected EPS growth that crushes the industry average.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
0 dimensions · 9 clusters
No impact vector found for this article yet.
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Zacks Investment Research
4h ago
